Filter
440
Text search:
Pharmaceutical
Prices
Featured
39
133
Language
Document type
204
126
51
24
18
6
6
4
1
Countries
21
19
16
14
9
9
8
8
8
7
7
7
7
7
7
7
6
6
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
194
33
17
12
11
9
2
Toolboxes
57
43
38
30
12
12
12
9
8
8
8
7
5
4
3
3
2
2
2
1
1
1
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
Dermatological Preparations For The Tropics
recommended
A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition
The 6th edition of the essential medicine list has been developed based on the 5th edition list of essential medicines, the National Standard Treatment Guidelines and Protocols 2013, list of laboratory commodities and List of Consumables used in public health facilities.
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
This guide can inform any partner that manages or supports public health supply chains. Ministries of health, technical assistance partners, or non-governmental organization (NGO) operating distribution systems can all benefit from conducting a costing exercise and can use the material presented in
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
National Medicines Policy 2015
recommended
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
First Revised Edition
March 2000
